Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 948

1.

Ozaki Procedure: 1,100 patients with up to 12 years of follow-up.

Ozaki S.

Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Oct 23;27(4):454. doi: 10.5606/tgkdc.dergisi.2019.01904. eCollection 2019 Oct. No abstract available.

2.

Publisher Correction: Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis.

Nakamoto T, Takahashi W, Haga A, Takahashi S, Kiryu S, Nawa K, Ohta T, Ozaki S, Nozawa Y, Tanaka S, Mukasa A, Nakagawa K.

Sci Rep. 2020 Feb 17;10(1):3073. doi: 10.1038/s41598-020-60086-3.

3.

Met-PET uptake index for total tumor resection: identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma.

Inoue A, Ohnishi T, Kohno S, Ohue S, Nishikawa M, Suehiro S, Matsumoto S, Ozaki S, Fukushima M, Kurata M, Kitazawa R, Shigekawa S, Watanabe H, Kunieda T.

Neurosurg Rev. 2020 Feb 15. doi: 10.1007/s10143-020-01258-7. [Epub ahead of print]

PMID:
32060762
4.

Activation of Water-Splitting Photocatalysts by Loading with Ultrafine Rh-Cr Mixed-Oxide Cocatalyst Nanoparticles.

Kurashige W, Mori Y, Ozaki S, Kawachi M, Hossain S, Kawawaki T, Shearer CJ, Iwase A, Metha GF, Yamazoe S, Kudo A, Negishi Y.

Angew Chem Int Ed Engl. 2020 Feb 11. doi: 10.1002/anie.201916681. [Epub ahead of print]

PMID:
32043742
5.

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.

Shigematsu H, Hirata T, Nishina M, Yasui D, Ozaki S.

Support Care Cancer. 2020 Feb 8. doi: 10.1007/s00520-020-05345-9. [Epub ahead of print]

PMID:
32036471
6.

The Interaction of Cyclic Naphthalene Diimide with G-Quadruplex under Molecular Crowding Condition.

Zou T, Sato S, Yasukawa R, Takeuchi R, Ozaki S, Fujii S, Takenaka S.

Molecules. 2020 Feb 4;25(3). pii: E668. doi: 10.3390/molecules25030668.

7.

Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature.

Kohno D, Inoue A, Fukushima M, Aki T, Matsumoto S, Suehiro S, Nishikawa M, Ozaki S, Shigekawa S, Watanabe H, Kitazawa R, Kunieda T.

Surg Neurol Int. 2020 Jan 17;11:8. doi: 10.25259/SNI_544_2019. eCollection 2020.

8.

Symbiotic riboflavin degradation by Microbacterium and Nocardioides bacteria.

Kanazawa H, Ozaki S, Doi Y, Masuo S, Takaya N.

Biosci Biotechnol Biochem. 2020 Jan 20:1-6. doi: 10.1080/09168451.2020.1715783. [Epub ahead of print]

PMID:
31959067
9.

JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version.

Isobe M, Amano K, Arimura Y, Ishizu A, Ito S, Kaname S, Kobayashi S, Komagata Y, Komuro I, Komori K, Takahashi K, Tanemoto K, Hasegawa H, Harigai M, Fujimoto S, Miyazaki T, Miyata T, Yamada H, Yoshida A, Wada T, Inoue Y, Uchida HA, Ota H, Okazaki T, Onimaru M, Kawakami T, Kinouchi R, Kurata A, Kosuge H, Sada KE, Shigematsu K, Suematsu E, Sueyoshi E, Sugihara T, Sugiyama H, Takeno M, Tamura N, Tsutsumino M, Dobashi H, Nakaoka Y, Nagasaka K, Maejima Y, Yoshifuji H, Watanabe Y, Ozaki S, Kimura T, Shigematsu H, Yamauchi-Takihara K, Murohara T, Momomura SI; JCS Joint Working Group.

Circ J. 2020 Jan 24;84(2):299-359. doi: 10.1253/circj.CJ-19-0773. Epub 2020 Jan 18. No abstract available.

10.

Prognostic significance of immunohistochemical subtypes based on the stage of B-cell differentiation in primary CNS lymphoma.

Inoue A, Ohnishi T, Kohno S, Matsumoto S, Nishikawa M, Ohue S, Ozaki S, Suehiro S, Kurata M, Fukushima M, Kitazawa R, Shigekawa S, Watanabe H, Kunieda T.

Int J Clin Exp Pathol. 2019 Apr 1;12(4):1457-1467. eCollection 2019.

11.

PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation.

Shimizu K, Sugiura D, Okazaki IM, Maruhashi T, Takegami Y, Cheng C, Ozaki S, Okazaki T.

Mol Cell. 2019 Dec 31. pii: S1097-2765(19)30925-6. doi: 10.1016/j.molcel.2019.12.012. [Epub ahead of print]

PMID:
31926851
12.

Body mass index modifies the association between frequency of alcohol consumption and incidence of hypertension in men but not in women: a retrospective cohort study.

Nishigaki D, Yamamoto R, Shinzawa M, Kimura Y, Fujii Y, Aoki K, Tomi R, Ozaki S, Yoshimura R, Taneike M, Nakanishi K, Nishida M, Yamauchi-Takihara K, Isaka Y, Moriyama T.

Hypertens Res. 2020 Jan 8. doi: 10.1038/s41440-019-0382-8. [Epub ahead of print]

PMID:
31913352
13.

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma.

Ozaki S, Harada T, Yagi H, Sekimoto E, Shibata H, Shigekiyo T, Fujii S, Nakamura S, Miki H, Kagawa K, Abe M.

Cancers (Basel). 2019 Dec 18;12(1). pii: E12. doi: 10.3390/cancers12010012.

14.

Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis.

Nakamoto T, Takahashi W, Haga A, Takahashi S, Kiryu S, Nawa K, Ohta T, Ozaki S, Nozawa Y, Tanaka S, Mukasa A, Nakagawa K.

Sci Rep. 2019 Dec 19;9(1):19411. doi: 10.1038/s41598-019-55922-0. Erratum in: Sci Rep. 2020 Feb 17;10(1):3073.

15.

Visual enhancement of Cone-beam CT by use of CycleGAN.

Kida S, Kaji S, Nawa K, Imae T, Nakamoto T, Ozaki S, Ohta T, Nozawa Y, Nakagawa K.

Med Phys. 2019 Dec 16. doi: 10.1002/mp.13963. [Epub ahead of print]

PMID:
31840269
16.

Mechanical characterization of an in-body tissue-engineered autologous collagenous sheet for application as an aortic valve reconstruction material.

Terazawa T, Kawashima T, Umeno T, Wada T, Ozaki S, Miyamoto S, Nakayama Y.

J Biomech. 2020 Jan 23;99:109528. doi: 10.1016/j.jbiomech.2019.109528. Epub 2019 Nov 18.

PMID:
31780124
17.

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.

Kageyama K, Ozaki S, Sato T.

J Vis Exp. 2019 Nov 6;(153). doi: 10.3791/59941.

PMID:
31762467
18.

Clinical Outcome and Diverse Risk Factors for Different Therapeutic Target Locations of Peripheral Artery Disease.

Ko T, Higashitani M, Uemura Y, Utsunomiya M, Yamaguchi T, Matsui A, Ozaki S, Tobita K, Kodama T, Morita H, Komuro I.

J Atheroscler Thromb. 2019 Nov 12. doi: 10.5551/jat.52647. [Epub ahead of print]

19.

Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.

Yokoyama N, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Hirano F, Sada KE, Matsumoto I, Kusaoi M, Amano H, Nagaoka S, Setoguchi K, Nagai T, Shimada K, Sugii S, Hashimoto A, Matsui T, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Migita K, Kono H, Hasegawa M, Kobayashi S, Yamada H, Nagasaka K, Sugihara T, Yamagata K, Ozaki S, Tamura N, Takasaki Y, Hashimoto H, Makino H, Arimura Y, Harigai M, Sato S, Sumida T, Tohma S, Takehara K, Tsuchiya N.

Sci Rep. 2019 Nov 8;9(1):16366. doi: 10.1038/s41598-019-52920-0.

20.

Cyclic Naphthalene Diimide with a Ferrocene Moiety as a Redox-Active Tetraplex-DNA Ligand.

Kaneyoshi S, Zou T, Ozaki S, Takeuchi R, Udou A, Nakahara T, Fujimoto K, Fujii S, Sato S, Takenaka S.

Chemistry. 2020 Jan 2;26(1):139-142. doi: 10.1002/chem.201903883. Epub 2019 Dec 5.

PMID:
31680317
21.

The effects of resection of the peripheral branches of the posterior nasal nerves in the inferior turbinate, with special focus on olfactory dysfunction.

Suzuki M, Yokota M, Ozaki S, Murakami S.

J Laryngol Otol. 2019 Dec;133(12):1046-1049. doi: 10.1017/S0022215119002238. Epub 2019 Nov 4.

PMID:
31679530
22.

Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma.

Sugiura I, Suzuki K, Ri M, Chou T, Takezako N, Sunami K, Ishida T, Izumi T, Ozaki S, Shumiya Y, Iida S.

Int J Hematol. 2020 Jan;111(1):57-64. doi: 10.1007/s12185-019-02754-3. Epub 2019 Oct 29.

PMID:
31664647
23.

Cardiac Rupture Due to Side Branch Occlusion After Stent Implantation - The Crime of Jailed Stent.

Asakura K, Homma T, Akutsu N, Fukamachi D, Ozaki S, Ohta H, Okumura Y, Hao H.

Circ J. 2020 Jan 24;84(2):295. doi: 10.1253/circj.CJ-19-0510. Epub 2019 Oct 18. No abstract available.

24.

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study.

Matsui A, Murata Y, Masuda N, Mori K, Takahashi M, Yamashiro K, Aogi K, Maeda S, Itou M, Ozaki S, Kuraoka K, Satou Y, Ichihara S, Tokunaga E, Taguchi K, Watanabe T, Suzuki H, Nagayama A, Nishimura R.

Oncotarget. 2019 Oct 1;10(55):5680-5689. doi: 10.18632/oncotarget.27163. eCollection 2019 Oct 1.

25.

Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand disease.

Shigekiyo T, Yagi H, Sekimoto E, Shibata H, Ozaki S, Matsumoto M.

Int J Hematol. 2020 Mar;111(3):467-470. doi: 10.1007/s12185-019-02753-4. Epub 2019 Oct 11.

PMID:
31605304
26.

A novel mode of DnaA-DnaA interaction promotes ADP dissociation for reactivation of replication initiation activity.

Sugiyama R, Kasho K, Miyoshi K, Ozaki S, Kagawa W, Kurumizaka H, Katayama T.

Nucleic Acids Res. 2019 Dec 2;47(21):11209-11224. doi: 10.1093/nar/gkz795.

27.

Regulation of replication initiation: lessons from Caulobacter crescentus.

Ozaki S.

Genes Genet Syst. 2019 Dec 10;94(5):183-196. doi: 10.1266/ggs.19-00011. Epub 2019 Sep 6.

28.

Finite Element Analysis of the Size Effect on Ceramic Strength.

Takeo K, Aoki Y, Osada T, Nakao W, Ozaki S.

Materials (Basel). 2019 Sep 6;12(18). pii: E2885. doi: 10.3390/ma12182885.

29.

[A Case of Right Frontal Dermoid Cyst with Temporal Imaging Changes in the Desease Course].

Nakamura Y, Iwata S, Inoue A, Ohue S, Fukumoto S, Ichikawa H, Onoue S, Ozaki S, Kohno K.

No Shinkei Geka. 2019 Jul;47(7):769-776. doi: 10.11477/mf.1436204021. Japanese.

PMID:
31358696
30.

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.

Iida S, Watanabe T, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Tobinai K.

Cancer Sci. 2019 Sep;110(9):2924-2932. doi: 10.1111/cas.14139. Epub 2019 Aug 10.

31.

PRELIMINARY EVALUATION OF A HAND-MADE RADIATION MONITOR'S POTENTIAL FOR PROVIDING ENERGY INFORMATION AS AN ADDITIONAL FEATURE FOR SECONDARY LEVEL RADIATION EDUCATION.

Katengeza EW, Ozaki S, Kato T, Kakefu T, Iimoto T.

Radiat Prot Dosimetry. 2019 Oct 1;184(3-4):535-538. doi: 10.1093/rpd/ncz076.

PMID:
31330006
32.

C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system.

Miyamoto T, Ozaki S, Inui A, Tanaka Y, Yamada Y, Matsumoto N.

Heart Vessels. 2020 Jan;35(1):46-51. doi: 10.1007/s00380-019-01466-2. Epub 2019 Jul 5.

PMID:
31278424
33.

Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study).

Aoki J, Nakazawa G, Ando K, Nakamura S, Tobaru T, Sakurada M, Okada H, Hibi K, Zen K, Habara S, Fujii K, Habara M, Ako J, Asano T, Ozaki S, Fusazaki T, Kozuma K; ELEGANT Investigators.

J Cardiol. 2019 Nov;74(5):436-442. doi: 10.1016/j.jjcc.2019.04.011. Epub 2019 Jun 24.

PMID:
31248751
34.

Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.

Masuda Y, Takeuchi K, Kodama T, Fujisaki T, Imaizumi Y, Otsuka E, Ozaki S, Hasebe S, Yakushijin Y.

Int J Clin Oncol. 2019 Dec;24(12):1620-1628. doi: 10.1007/s10147-019-01481-3. Epub 2019 Jun 6.

PMID:
31172332
35.

Small intestinal intussusception in an adult.

Takada K, Fujimoto N, Ozeki T, Nishimura J, Miyamoto Y, Asano M, Fuchimoto Y, Wada S, Ozaki S, Igawa T, Sonobe H, Kishimoto T.

J Clin Pathol. 2019 Jul;72(7):510. doi: 10.1136/jclinpath-2017-204973. Epub 2019 Jun 6. No abstract available.

PMID:
31171576
36.

High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis.

Kiyokawa T, Hanaoka H, Iida H, Ishimori K, Takakuwa Y, Okazaki T, Ozaki S, Kawahata K.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1623435. [Epub ahead of print]

PMID:
31135249
37.

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jul;110(1):125-126. doi: 10.1007/s12185-019-02663-5.

PMID:
31119612
38.

Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.

Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, Suzuki K, Isoda A, Matsumoto M, Sawamura M, Sunami K, Takezako N, Hagiwara S, Kuroda Y, Chou T, Nagura E, Shimizu K.

Ann Hematol. 2019 Jul;98(7):1703-1711. doi: 10.1007/s00277-019-03702-1. Epub 2019 May 2.

PMID:
31049648
39.

How Do Richness and Composition of Diet Shape Trace Metal Exposure in a Free-Living Generalist Rodent, Apodemus sylvaticus.

Ozaki S, Fritsch C, Valot B, Mora F, Cornier T, Scheifler R, Raoul F.

Environ Sci Technol. 2019 May 21;53(10):5977-5986. doi: 10.1021/acs.est.8b07194. Epub 2019 May 2.

PMID:
31002242
40.

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ.

Iwasa M, Harada T, Oda A, Bat-Erdene A, Teramachi J, Tenshin H, Ashtar M, Oura M, Sogabe K, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Abe M.

Oncotarget. 2019 Mar 8;10(20):1903-1917. doi: 10.18632/oncotarget.26726. eCollection 2019 Mar 8.

41.

JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).

Iida S, Ishida T, Murakami H, Ozaki S, Abe M, Hata H, Shimazaki C.

Int J Hematol. 2019 May;109(5):509-538. doi: 10.1007/s12185-019-02636-8. Epub 2019 Apr 4. Review. No abstract available.

PMID:
30949913
42.

Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.

Kamiya Y, Chou T, Murakami H, Handa H, Ozaki S, Shimazaki C, Fuchida SI, Okada J, Itoh J, Sugiyama S, Shimizu K.

Hematol Oncol. 2019 Aug;37(3):316-318. doi: 10.1002/hon.2611. Epub 2019 Apr 26. No abstract available.

PMID:
30938836
43.

Chloride intracellular channel protein 2 in cancer and non-cancer human tissues: relationship with tight junctions.

Ueno Y, Ozaki S, Umakoshi A, Yano H, Choudhury ME, Abe N, Sumida Y, Kuwabara J, Uchida R, Islam A, Ogawa K, Ishimaru K, Yorozuya T, Kunieda T, Watanabe Y, Takada Y, Tanaka J.

Tissue Barriers. 2019;7(1):1593775. doi: 10.1080/21688370.2019.1593775. Epub 2019 Mar 31.

44.

Capturing spontaneous activity in the medial prefrontal cortex using near-infrared spectroscopy and its application to schizophrenia.

Hosomi F, Yanagi M, Kawakubo Y, Tsujii N, Ozaki S, Shirakawa O.

Sci Rep. 2019 Mar 27;9(1):5283. doi: 10.1038/s41598-019-41739-4.

45.

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.

Shigematsu H, Nishina M, Yasui D, Hirata T, Ozaki S.

World J Surg Oncol. 2019 Feb 23;17(1):41. doi: 10.1186/s12957-019-1585-9.

46.

Escherichia coli CrfC Protein, a Nucleoid Partition Factor, Localizes to Nucleoid Poles via the Activities of Specific Nucleoid-Associated Proteins.

Taniguchi S, Kasho K, Ozaki S, Katayama T.

Front Microbiol. 2019 Feb 7;10:72. doi: 10.3389/fmicb.2019.00072. eCollection 2019.

47.

Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.

Hatta K, Hasegawa H, Imai A, Sudo Y, Morikawa F, Katayama S, Watanabe H, Ishizuka T, Nakamura M, Misawa F, Fujita K, Ozaki S, Umeda K, Nakamura H, Sawa Y, Sugiyama N; JAST study group.

Asian J Psychiatr. 2019 Feb;40:82-87. doi: 10.1016/j.ajp.2019.02.005. Epub 2019 Feb 8.

PMID:
30772732
48.

Structure-based virtual screening for insect ecdysone receptor ligands using MM/PBSA.

Horoiwa S, Yokoi T, Masumoto S, Minami S, Ishizuka C, Kishikawa H, Ozaki S, Kitsuda S, Nakagawa Y, Miyagawa H.

Bioorg Med Chem. 2019 Mar 15;27(6):1065-1075. doi: 10.1016/j.bmc.2019.02.011. Epub 2019 Feb 5.

PMID:
30770256
49.

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.

Namba N, Kawasaki A, Sada KE, Hirano F, Kobayashi S, Yamada H, Furukawa H, Shimada K, Hashimoto A, Matsui T, Nagasaka K, Sugihara T, Suzuki A, Yamagata K, Sumida T, Tohma S, Homma S, Ozaki S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS).

Ann Rheum Dis. 2019 Aug;78(8):1144-1146. doi: 10.1136/annrheumdis-2018-214263. Epub 2019 Feb 14. No abstract available.

PMID:
30765393
50.

A low perfusion-metabolic mismatch in 99m Tl and 123 I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement.

Iida H, Hanaoka H, Okada Y, Kiyokawa T, Takakuwa Y, Yamada H, Okazaki T, Ozaki S, Yamaguchi K, Nakajima Y, Kawahata K.

Int J Rheum Dis. 2019 Jun;22(6):1008-1015. doi: 10.1111/1756-185X.13508. Epub 2019 Feb 6.

PMID:
30729690

Supplemental Content

Support Center